Why most patients with hepatitis delta virus infection are seronegative for hepatitis B e antigen. A prospective controlled study.

Abstract	A prospective age/sex matched control and follow-up study was conducted to explore the reason(s) for the association of hepatitis delta virus (HDV) infection with hepatitis B e antigen (HBeAg) negative hepatitis B surface antigen (HBsAg) carrier state. Over a 3-year period, a total of 110 patients (104 males and six females) with acute HDV superinfection were documented in our unit. Twenty-four (21.8%) of them were HBeAg positive at the onset of acute HDV infection. In the control study, 110 age- and sex-matched asymptomatic HBsAg carriers with normal serum transaminase, as well as 110 age- and sex-matched patients with chronic type B hepatitis were randomly selected from the computer files of the same 3-year period of entry. The prevalence of serum HBeAg in patients with HDV infection was similar to that of asymptomatic HBsAg carriers (20.9%), but significantly lower than that of the patients with chronic type B hepatitis (72.7%). In a follow-up study of 16 HBeAg-positive patients with HDV infection, eight (50%) cleared HBeAg and three (18.8%) seroconverted to anti-HBe within 3 months. The HBeAg clearance rate was significantly higher than for chronic type B hepatitis and asymptomatic carriers (p less than 0.01). The results suggest that the low prevalence of serum HBeAg in HDV infection simply reflects the HBeAg/anti-HBe status of the asymptomatic HBsAg carriers in the population under study. Also in some patients HDV superinfection may itself suppress HBV and thus clear HBeAg.
Authors	Y F Liaw, J T Dong, K W Chiu, I S Sheen, C M Chu
Journal	Journal of hepatology (J Hepatol) Vol. 12 Issue 1 Pg. 106-9 (Jan 1991) ISSN: 0168-8278 [Print] Netherlands
PMID	2007766 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References	Hepatitis B e Antigens
Topics	Adolescent Adult Age Factors Case-Control Studies Female Follow-Up Studies Hepatitis B e Antigens (analysis) Hepatitis D (blood, diagnosis, epidemiology, immunology) Humans Male Middle Aged Prospective Studies Serologic Tests Sex Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!